Anaphylaxis treatment: the details.
Ellrodt
Axel
A
D000707:Anaphylaxis / Q000139:chemically induced / Q000188:drug therapy* / Q000401:mortality; D018926:Anti-Allergic Agents / Q000008:administration & dosage / Q000009:adverse effects; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D002511:Cephalosporins / Q000009:adverse effects; D004155:Diphenhydramine / Q000008:administration & dosage / Q000009:adverse effects; D006635:Histamine H2 Antagonists / Q000627:therapeutic use*; D006801:Humans; D011899:Ranitidine / Q000627:therapeutic use*
D018926:Anti-Allergic Agents; D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D006635:Histamine H2 Antagonists; D011899:Ranitidine; D004155:Diphenhydramine